|
Pathophysiology
Citations 111-120 of 1277 total displayed.
|
Past content
(since Jan 1999):
|
- Vascular Medicine
Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction
- Akio Kawakami, Mizuko Osaka, Mariko Tani, Hiroshi Azuma, Frank M. Sacks, Kentaro Shimokado, and Masayuki Yoshida
Circulation 2008;118:731-742; published online before print as doi:10.1161/CIRCULATIONAHA.108.784785
[Abstract]
[Full text]
- Vascular Medicine
Antisense Oligonucleotide Directed to Human Apolipoprotein B-100 Reduces Lipoprotein(a) Levels and Oxidized Phospholipids on Human Apolipoprotein B-100 Particles in Lipoprotein(a) Transgenic Mice
- Esther Merki, Mark J. Graham, Adam E. Mullick, Elizabeth R. Miller, Rosanne M. Crooke, Robert E. Pitas, Joseph L. Witztum, and Sotirios Tsimikas
Circulation 2008;118:743-753; published online before print as doi:10.1161/CIRCULATIONAHA.108.786822
[Abstract]
[Full text]
- Contemporary Reviews in Cardiovascular Medicine
Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia
- Daniel Steinberg, Christopher K. Glass, and Joseph L. Witztum
Circulation 2008;118:672-677, doi:10.1161/CIRCULATIONAHA.107.753152
[Full text]
- Articles
Antisense Oligonucleotide Directed to Human Apolipoprotein B-100 Reduces Lipoprotein(a) Levels and Oxidized Phospholipids on Human Apolipoprotein B-100 Particles in Lipoprotein(a) Transgenic Mice
- Esther Merki, Mark J. Graham, Adam E. Mullick, Elizabeth R. Miller, Rosanne M. Crooke, Robert E. Pitas, Joseph L. Witztum, and Sotirios Tsimikas
Circulation published July 28, 2008, doi:10.1161/CIRCULATIONAHA.108.786822
[Abstract]
- Articles
Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction
- Akio Kawakami, Mizuko Osaka, Mariko Tani, Hiroshi Azuma, Frank M. Sacks, Kentaro Shimokado, and Masayuki Yoshida
Circulation published July 28, 2008, doi:10.1161/CIRCULATIONAHA.108.784785
[Abstract]
- Correspondence
Letter by Secchiero and Zauli Regarding Article, "Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr(–/–) Mice"
- Paola Secchiero and Giorgio Zauli
Circulation 2008;118:e18, doi:10.1161/CIRCULATIONAHA.108.765776
[Full text]
- Correspondence
Response to Letter Regarding Article, "Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr(–/–) Mice"
- Sean Morony, Denise Dwyer, Marina Stolina, Paul J. Kostenuik, Yin Tintut, Zina Zhang, Linda L. Demer, Russell C. Cattley, and Gwyneth Van
Circulation 2008;118:e19, doi:10.1161/CIRCULATIONAHA.108.782649
[Full text]
- AHA Conference Proceedings
Development of Appropriate Coronary Heart Disease Risk Prediction Models in HIV-Infected Patients
- Morris Schambelan, Peter W.F. Wilson, Kevin E. Yarasheski, W. Todd Cade, Victor G. Dávila-Román, Ralph B. D’Agostino, Sr, Tarek A. Helmy, Matthew Law, Kristin E. Mondy, Sharon Nachman, Linda R. Peterson, Signe W. Worm, and for Working Group 5
Circulation 2008;118:e48-53e; published online before print as doi:10.1161/CIRCULATIONAHA.107.189627
[Full text]
- Vascular Medicine
Impact of Plasma Oxidized Low-Density Lipoprotein Removal on Atherosclerosis
- Yasushi Ishigaki, Hideki Katagiri, Junhong Gao, Tetsuya Yamada, Junta Imai, Kenji Uno, Yutaka Hasegawa, Keizo Kaneko, Takehide Ogihara, Hisamitsu Ishihara, Yuko Sato, Kenji Takikawa, Norihisa Nishimichi, Haruo Matsuda, Tatsuya Sawamura, and Yoshitomo Oka
Circulation 2008;118:75-83; published online before print as doi:10.1161/CIRCULATIONAHA.107.745174
[Abstract]
[Full text]
- Editorials
Diversity of Denizens of the Atherosclerotic Plaque: Not All Monocytes Are Created Equal
- Peter Libby, Matthias Nahrendorf, Mikael J. Pittet, and Filip K. Swirski
Circulation 2008;117:3168-3170, doi:10.1161/CIRCULATIONAHA.108.783068
[Full text]
|
|
